Colorectal Cancer Trial, Recruiting (NCT07035886)

Colorectal Cancer Trial, Recruiting NCT07035886 Sponsor: Takeda Condition: Colorectal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07035886 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Colorectal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older.
People who are starting or will be treated with Fruzaqla in line with the approved guidelines in South Korea.
People who give their voluntary consent to take part in the study.

Who may not be able to join:

People for whom Fruzaqla is listed as unsuitable or carries risks that mean it should not be started, according to the product guidelines.
People who are currently taking part in another clinical trial testing treatments for advanced colorectal cancer.
People who are pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Study Director, Takeda

Phone: +1-877-825-3327

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07035886

Sponsor: Takeda

Phase: Not Applicable

Status: Recruiting

Condition: Colorectal Cancer

Trial contact: +1-877-825-3327

More information: https://clinicaltrials.gov/study/NCT07035886

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older.
People who are starting or will be treated with Fruzaqla in line with the approved guidelines in South Korea.
People who give their voluntary consent to take part in the study.

Who may not be able to join:

People for whom Fruzaqla is listed as unsuitable or carries risks that mean it should not be started, according to the product guidelines.
People who are currently taking part in another clinical trial testing treatments for advanced colorectal cancer.
People who are pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Takeda

Registry

ClinicalTrials.gov

Start date

29 September 2025

Est. completion

1 September 2029

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Number of Participants with Any Adverse Events (AEs), Adverse Drug Reaction (ADRs), Expected and Unexpected AEs and ADRs; Number of Participants with Any Serious Adverse Events (SAEs), Serious Adverse Drug Reaction (SADRs), Expected and Unexpected SAEs and SADRs, AEs Leading to Death; Number of Participants with AEs with Grade 3 or Higher; Number of Participants who Reported the Events Related to Important Risks in the Risk Management Plan (RMP)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov